已收盘 12-12 16:00:00 美东时间
-0.410
-0.45%
Okta's sales reorganization boosts productivity, leading analyst to maintain Buy rating. AI security and product momentum show promise.
今天 01:06
Needham analyst Mike Cikos reiterates Okta (NASDAQ:OKTA) with a Buy and maintains $110 price target.
12-12 18:28
Key Takeaways Gaining traction in cybersecurity tools could help signal a tran...
12-09 02:54
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Recent analyst actions have spotlighted critical shifts in the market, with attention given to companies such as Tilray Brands (TLRY) and Marvell Technology (MRVL). Tilray has seen an improvement in i...
12-05 01:38
英伟达芯片将解禁?传对华销售芯片禁令遭否决;目标7100点!美银预计标普500指数明年继续涨;热门中概盘前普涨,蔚来涨近4%,哔哩哔哩涨超3%>>
12-04 21:07
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
12-04 09:38
Okta Inc (NASDAQ: OKTA) shares rose after reporting upbeat Q3 results. Analysts have mixed ratings, with Scotiabank maintaining Perform rating.
12-04 00:46
Stock futures showed mixed signals Wednesday, as softer private payroll figures heightened prospects for a December Fed rate cut, offset by concerns over Microsoft's difficulties in generating revenue...
12-03 23:38
美股周三盘前,Okta公司股价下跌6.1%。该公司报告第三季度剔除一次性项目后的每股收益为82美分,营收为7.42亿美元,而分析师预期为每股收益76美分,营...
12-03 22:16